Tag: scholz
SIGN UP FOR OUR NEWSLETTER


Quick Search

Reset

Who's Really at Risk for What?

Tue 31 May 2005

PCRI Insights May, 2005 vol. 8, no. 2 By Mark C. Scholz, MD, Director, Prostate Oncology Specialists, Marina del Rey, CA, and Ralph Blum PC Survivor   Editor’s Note: This is an article by Dr. Scholz providing advice to prostate cancer patients about health issues unrelated to prostate cancer. The goal of the article isRead More ›

The Way to Find the Best Available Treatment for Your PC: Advice for Men Newly Diagnosed with Prostate Cancer

Tue 31 Aug 2004

PCRI Insights August, 2004 vol. 7, no. 3 By Mark Scholz, M.D., Prostate Oncology Specialists “You mean you’ve never heard of spectroscopy being used in prostate cancer staging?” Don, a recently diagnosed prostate cancer (PC) patient, was astonished to learn that the doctor treating him was unaware of this application of this new technology. DonRead More ›

Newly Diagnosed Prostate Cancer: Evaluating the Options — Part 3 of 3

Sat 21 Feb 2004

Reprinted from PCRI Insights February 2004 v 7.1 By Mark Scholz, M.D., Prostate Oncology Specialists, Marina del Rey, CA Background This is the third article of a three-part series describing treatment alternatives for newly diagnosed prostate cancer patients. In this part, treatment for men who are at higher risk for micro-metastatic spread outside the prostateRead More ›

Newly Diagnosed Prostate Cancer: Evaluating the Options — Part 2 of 3

Sun 31 Aug 2003

PCRI Insights August 2003 vol. 6, no. 3 By Mark Scholz, M.D., Prostate Oncology Specialists Introduction Newly diagnosed prostate cancer is not a single disease but a spectrum of diseases ranging from very low-risk, prostate-confined variants up to high-grade disease that has already spread outside the prostate. In Part One of this series, Risk CategoryRead More ›

Newly Diagnosed Prostate Cancer: Evaluating the Options — Part 1 of 3

Fri 28 Feb 2003

PCRI Insights February 2003 vol. 6, no. 1 By Mark Scholz, M.D., Prostate Oncology Specialists Newly diagnosed prostate cancer is a disease in transition. Historically, because it was diagnosed in the advanced stages, the diagnosis of prostate cancer portended an early death just like many other common cancers. Over the last 10 years, however, theRead More ›

Anemia Associated With Androgen Deprivation (AAAD)

Sat 1 May 1999

by S. B. Strum, J. E. McDermed, M. C. Scholz, H. Johnson and G. Tisman This article originally appeared as a booklet, last edited May, 1999. An Overview And Description Of This Adverse Effect Commonly Seen In Prostate Cancer Patients Receiving Combination Hormone Blockade ABSTRACT Objectives To describe the incidence, time to onset and extentRead More ›